You are here: Industry Insights > Boehringer Ingelheim

News List

Boehringer Ingelheim’s Ofev takes #FierceMadness ad championship fiercepharma
April 09, 2019
Some votes for Ofev were also votes against the polarizing jingle “Easy as 1,2,3” play on Jackson Five tune for Trelegy.
Boehringer Ingelheim enhances oncology R&D with novel MacroDel delivery technology via acquisition of ICD Therapeutics worldpharmanews
April 08, 2019
Boehringer Ingelheim announced that it acquired ICD Therapeutics. The acquisition includes rights to ICD's innovative MacroDel biologics-delivery platform.
Boehringer Ingelheim acquires ICD Therapeutics biospectrumasia
April 02, 2019
Boehringer Ingelheim has announced that it has acquired ICD Therapeutics.
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD worldpharmanews
March 27, 2019
Boehringer Ingelheim has filed for regulatory approval of nintedanib in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD) with the FDA and EMA.
Boehringer Ingelheim files for regulatory approval of nintedanib pharmaceutical-technology
March 20, 2019
Boehringer Ingelheim has filed regulatory submissions with the Food and Drug Administration (FDA) and European Medicines Agency (EMA) for approval of nintedanib in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD).
Boehringer Ingelheim (Canada) Ltd. and IBM Canada announce first of its kind collaboration to integrate blockchain technology into clinical trials worldpharmanews
February 13, 2019
Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology in clinical trials.
Bioharmony Therapeutics and Boehringer Ingelheim Collaborate to Advance Bacteriophage Lysin Therapeutics pharmafocusasia
January 17, 2019
Bioharmony Therapeutics, Inc., a biopharmaceutical company focusing on the development of novel therapeutics for hard to treat bacterial infections.....
Boehringer Ingelheim initiates a collaborative partnership with Science 37 to accelerate patient centricity in the development of novel therapies expressbpd
January 14, 2019
Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running remote clinical trials.
Boehringer's France restructure will cull over 300 jobs pharmafile
December 12, 2018
Boehringer Ingelheim is set to follow in the recent steps of Sanofi with the announcement of a cull of over 300 employees in France – around 10% of the company’s total workforce in the country.
Boehringer Ingelheim to cut 10 percent of workforce in France firstwordpharma
December 11, 2018
According to French media reports on Monday, Boehringer Ingelheim is cutting around 10 percent of its workforce in France under a reorganisation of its activities in the country.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page